ArticleOncotarget2012

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.

Roland H Stauber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.